Question 1

How many shares of QNCX does BlackRock, Inc. own?

Accepted Answer

BlackRock, Inc. previously held 0 shares of QNCX (QUINCE THERAPEUTICS INC) before exiting the position in 2026-Q2.

Question 2

What is BlackRock, Inc.'s QNCX position worth?

Accepted Answer

BlackRock, Inc.'s QNCX position was last reported at $0 in 2026-Q2 before the exit.

Question 3

Is BlackRock, Inc. buying or selling QNCX?

Accepted Answer

In 2026-Q2, BlackRock, Inc. exited their QNCX position entirely (-100.0% change in shares).

Question 4

When did BlackRock, Inc. first buy QNCX?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in QNCX in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$18.19	0
2026-Q1	Increased	473,259	+0.3%	$47,989	0.0%	$0.10	14
2025-Q4	Increased	471,989	+36.6%	$1.6M	0.0%	$3.26	23
2025-Q3	Increased	345,461	+2.9%	$563,101	0.0%	$1.61	17
2025-Q2	Decreased	335,738	-2.8%	$553,968	0.0%	$1.55	0
2025-Q1	Decreased	345,448	-22.9%	$459,446	0.0%	$1.35	0
2024-Q4	New	447,733	—	$837,261	0.0%	$1.85	38